Discover how CLEC3B, a little-known gene, impacts non-small cell lung cancer through its role in the immune microenvironment and potential as a diagnostic biomarker.
Landmark study showing ALIMTA® (pemetrexed) improved survival in non-small cell lung cancer patients with adenocarcinoma or large cell carcinoma histologies.
An in-depth analysis of NSCLC treatment evolution over 20 years through bibliometric study of the 100 most influential scientific papers.